Miglitol (Orient Pharma Co., Ltd.)


Welcome to the PulseAid listing for the Miglitol drug offered from Orient Pharma Co., Ltd.. This alpha Glucosidase Inhibitors [MoA],alpha-Glucosidase Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Orient Pharma Co., Ltd.
NON-PROPRIETARY NAME: Miglitol
SUBSTANCE NAME: MIGLITOL
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: alpha Glucosidase Inhibitors [MoA],alpha-Glucosidase Inhibitor [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET, COATED
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2015-07-31
END MARKETING DATE: 0000-00-00


Miglitol HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMiglitol from Orient Pharma Co., Ltd.
LABELER NAME: Orient Pharma Co., Ltd.
DEA SCHEDULE:
ACTIVE STRENGTH: 25(mg/1)
START MARKETING DATE: 2015-07-31
END MARKETING DATE: 0000-00-00
PRODUCT ID: 76333-125_71fe01c0-610b-477e-8709-d194ebde8624
PRODUCT NDC: 76333-125
APPLICATION NUMBER: ANDA203965

Other MIGLITOL Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Orient Pharma Co., Ltd.Miglitol
Pharmacia and Upjohn Company LLCGlyset
Sun Pharmaceutical Industries Ltd.Miglitol